Crossmark

Methylation-specific qPCR for the EBV C promoter to quantify EBV methylation

Published Online: 2025-10-30

Authors

George, Logan

Rubinstein, Paul G.

Petr, Jennifer

Noy, Ariela

Haley, Lisa

Adams, Emily

Xian, Rena R.

Ambinder, Richard F.
Funding

Funding for this research was provided by:

National Cancer Institute (P30CA006973, UM1CA121947, U01CA284811, UM1AI164566, P30CA006973, UM1CA121947, U01CA284811, UM1AI164566, P30CA006973, UM1CA121947, U01CA284811, UM1AI164566, P30CA006973, UM1CA121947, U01CA284811, UM1AI164566)
License Information

Text and Data Mining valid from 2025-10-30

Version of Record valid from 2025-10-30
More Information

Article History

Received: 10 July 2025

Accepted: 23 September 2025

First Online: 30 October 2025

Declarations

:

: Informed consent was obtained from a subset of the participants involved in the study with the remaining participants’ consent being waived as use of existing biospecimens, which was approved under IRB00326830.

: The study was conducted in accordance with the Declaration of Helsinki and approved by the Johns Hopkins School of Medicine Institutional Review Board (IRB00165673; June 20th, 2018; IRB00326830; August 18, 2022).

: The authors declare no competing interests.

Document is current